A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
HiFiBiO Therapeutics
Pfizer
University of Virginia
Incyte Corporation
Incyte Corporation
Sotio Biotech Inc.
Molecular Templates, Inc.
University of Florida
Fate Therapeutics
Polaris Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mirna Therapeutics, Inc.